Plague | ISARIC

Researchers successfully enrol over 220 cases for landmark plague trial

by Wajeeha Malik | May 8, 2024 | News

The first randomised controlled trial powered to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 cases of confirmed or probable bubonic plague in Madagascar, marking a critical milestone in plague treatment research. Plague has...

The impact of COVID-19 on clinical research for Neglected Tropical Diseases (NTDs): a case study of bubonic plague

by Eamonn | Apr 23, 2024

Among the many collaterals of the COVID-19 pandemic is the disruption of health services and vital clinical research. COVID-19 has magnified the challenges faced in research and threatens to slow research for urgently needed therapeutics for Neglected Tropical...

Bubonic plague: can the size of buboes be accurately and consistently measured with a digital calliper?

by Wajeeha Malik | Dec 19, 2023

Draft framework for clinical trials seeks public feedback

by Wajeeha Malik | Dec 18, 2023 | Frameworks, News, Research

18 December 2023: The International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) is working with partners to create a framework to support endpoint selection for clinical trials for outbreak-prone infectious diseases. The project members, which...

A systematic review of the clinical profile of patients with bubonic plague and the outcome measures used in research settings

by Wajeeha Malik | Nov 9, 2023

Researchers successfully enrol over 220 cases for landmark plague trial

The impact of COVID-19 on clinical research for Neglected Tropical Diseases (NTDs): a case study of bubonic plague

Bubonic plague: can the size of buboes be accurately and consistently measured with a digital calliper?

Draft framework for clinical trials seeks public feedback

A systematic review of the clinical profile of patients with bubonic plague and the outcome measures used in research settings

Cookies Policy